Carcinoma, Large Cell: Clinical Trials

2 trials for Carcinoma, Large Cell, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2

Follow Carcinoma, Large Cell: new trials by email Literature Review of Carcinoma, Large Cell trials Research Report on Carcinoma, Large Cell

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly
nab-paclitaxel, Carboplatin - Non-Small Cell Lung Cancer, Carcinoma
Phase 4CompletedCelgene1432014-06-092018-09-24
RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation
RAD001, Paclitaxel, Carboplatin - Carcinoma, Large Cell, Neuroendocrine Tumors
Phase 4CompletedNovartis Pharmaceuticals492011-04-012016-03-30

Narrower conditions

Lung Neoplasms (2)  ·  Adenocarcinoma (1)  ·  Carcinoma (1)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Carcinoma, Squamous Cell (1)  ·  Neuroendocrine Tumors (1)

Broader conditions

Lung Diseases (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Respiratory Tract Diseases (2)  ·  Respiratory Tract Neoplasms (2)  ·  Thoracic Neoplasms (2)  ·  Bronchial Neoplasms (1)  ·  Carcinoma (1)  ·  Carcinoma, Bronchogenic (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplasms, Squamous Cell (1)  ·  Neuroectodermal Tumors (1)

Interventions

Carboplatin (2)  ·  130-nm albumin-bound paclitaxel (1)  ·  Albumin-Bound Paclitaxel (1)  ·  Everolimus (1)  ·  Paclitaxel (1)

Sponsors

Celgene (1)  ·  Novartis Pharmaceuticals (1)

Countries

Germany (1)  ·  United States (1)

Top investigators

Teng Jin Ong (1)

Results publications

PMID 28535181